Agilent Technologies Inc. logo

Agilent Technologies Inc. (A)

Market Closed
3 Jun, 20:00
NYSE NYSE
$
137. 40
+2.35
+1.7401%
$
38.16B Market Cap
- P/E Ratio
1.02% Div Yield
2.42M Volume
- Eps
$ 135.05
Previous Close
Add Transaction
Day Range
133.7 138.97
Year Range
108.35 160.27
Want to track A and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Agilent Technologies (A) Q2 Earnings and Revenues Top Estimates

Agilent Technologies (A) Q2 Earnings and Revenues Top Estimates

Agilent Technologies (A) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.22 per share a year ago.

Zacks | 1 year ago
Curious about Agilent (A) Q2 Performance? Explore Wall Street Estimates for Key Metrics

Curious about Agilent (A) Q2 Performance? Explore Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Agilent (A), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2025.

Zacks | 1 year ago
Will Agilent (A) Beat Estimates Again in Its Next Earnings Report?

Will Agilent (A) Beat Estimates Again in Its Next Earnings Report?

Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 1 year ago
The Preferred Stock IPO Market Is Frozen

The Preferred Stock IPO Market Is Frozen

This month's preferred stock IPO market is frozen, dominated by “Par Cross” and “Insider Buying” alerts, reflecting investor uncertainty due to trade tensions. The trade war and tariffs have created significant market volatility, causing companies to withdraw earnings guidance and defer investment decisions. Preferred stocks and baby bonds offer fixed payments, making them attractive during uncertain times, as they provide a “known return” amidst market unpredictability.

Seekingalpha | 1 year ago
Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Zacks | 1 year ago
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names

Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Zacks | 1 year ago
Fear Creates Fortunes: Grab These 7 Blue-Chip Bargains Today

Fear Creates Fortunes: Grab These 7 Blue-Chip Bargains Today

Fear at extremes: Investor and consumer sentiment is near historic lows, signaling a high-probability buying opportunity, historically followed by strong 12-month gains. Economic reality check: Real-time economic indicators show GDP growth of more than 2%, despite widespread recession fears, highlighting a disconnect between sentiment and fundamentals. Inflation truth vs. hype: Real-time data shows inflation is falling, contradicting consumer fears and demonstrating that stagflation panic may be premature.

Seekingalpha | 1 year ago
Agilent Technologies, Inc. (A) TD Cowen 45th Annual Healthcare Conference (Transcript)

Agilent Technologies, Inc. (A) TD Cowen 45th Annual Healthcare Conference (Transcript)

Agilent Technologies, Inc. (NYSE:A ) TD Cowen 45th Annual Healthcare Conference Call March 4, 2025 9:50 AM ET Company Participants Padraig McDonnell - Chief Executive Officer Bob McMahon - Chief Financial Officer Conference Call Participants Daniel Brennan - TD Cowen Daniel Brennan Alright, good. I guess we'll start in a minute or two early here, great day two of the TD Cowen Global Healthcare Conference.

Seekingalpha | 1 year ago
Unlocking Agilent (A) International Revenues: Trends, Surprises, and Prospects

Unlocking Agilent (A) International Revenues: Trends, Surprises, and Prospects

Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Zacks | 1 year ago
Agilent Technologies, Inc. (A) Q1 2025 Earnings Call Transcript

Agilent Technologies, Inc. (A) Q1 2025 Earnings Call Transcript

Agilent Technologies, Inc. (NYSE:A ) Q1 2025 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Parmeet Ahuja - Vice President of Investor Relations Padraig McDonnell - President and Chief Executive Officer Robert W. McMahon - Senior Vice President and Chief Financial Officer Simon May - President of Life Sciences and Diagnostics Markets Group Angelica Riemann - President of Agilent CrossLab Group Mike Zhang - President of Applied Markets Group Conference Call Participants Rachel Vatnsdal - J.P.

Seekingalpha | 1 year ago
Agilent (A) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Agilent (A) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Agilent (A) give a sense of how its business performed in the quarter ended January 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 1 year ago
Agilent Technologies (A) Q1 Earnings and Revenues Beat Estimates

Agilent Technologies (A) Q1 Earnings and Revenues Beat Estimates

Agilent Technologies (A) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.29 per share a year ago.

Zacks | 1 year ago
Loading...
Load More